Mayumi Muto

724 total citations
24 papers, 441 citations indexed

About

Mayumi Muto is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Mayumi Muto has authored 24 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 12 papers in Neurology and 4 papers in Rheumatology. Recurrent topics in Mayumi Muto's work include Multiple Sclerosis Research Studies (18 papers), Peripheral Neuropathies and Disorders (10 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers). Mayumi Muto is often cited by papers focused on Multiple Sclerosis Research Studies (18 papers), Peripheral Neuropathies and Disorders (10 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers). Mayumi Muto collaborates with scholars based in Japan and United States. Mayumi Muto's co-authors include Satoshi Kuwabara, Masahiro Mori, Akiyuki Uzawa, Tomohiko Uchida, Hiroki Masuda, Saeko Masuda, Ryohei Ohtani, Shoichi Ito, Fumio Nomura and Setsu Sawai and has published in prestigious journals such as Scientific Reports, Journal of Neurology Neurosurgery & Psychiatry and Journal of the American Academy of Dermatology.

In The Last Decade

Mayumi Muto

23 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mayumi Muto Japan 13 284 195 90 83 82 24 441
Markus Breu Austria 10 216 0.8× 238 1.2× 35 0.4× 39 0.5× 74 0.9× 21 390
Csilla Rózsa Hungary 16 217 0.8× 219 1.1× 23 0.3× 97 1.2× 72 0.9× 32 535
Yanyu Chang China 13 208 0.7× 229 1.2× 55 0.6× 123 1.5× 62 0.8× 42 434
Hiroyuki Yahikozawa Japan 15 91 0.3× 181 0.9× 45 0.5× 184 2.2× 29 0.4× 37 571
Leoni Rolfes Germany 15 286 1.0× 133 0.7× 87 1.0× 77 0.9× 63 0.8× 39 524
Takeshi Kezuka Japan 14 153 0.5× 124 0.6× 56 0.6× 65 0.8× 124 1.5× 20 495
Yuji Tomizawa Japan 11 144 0.5× 112 0.6× 33 0.4× 44 0.5× 53 0.6× 36 319
Ryohei Ohtani Japan 12 230 0.8× 140 0.7× 68 0.8× 75 0.9× 50 0.6× 28 345
Vincent Damotte United States 8 123 0.4× 88 0.5× 61 0.7× 66 0.8× 40 0.5× 12 369
Yaqing Shu China 12 150 0.5× 212 1.1× 49 0.5× 111 1.3× 55 0.7× 38 515

Countries citing papers authored by Mayumi Muto

Since Specialization
Citations

This map shows the geographic impact of Mayumi Muto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayumi Muto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayumi Muto more than expected).

Fields of papers citing papers by Mayumi Muto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mayumi Muto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayumi Muto. The network helps show where Mayumi Muto may publish in the future.

Co-authorship network of co-authors of Mayumi Muto

This figure shows the co-authorship network connecting the top 25 collaborators of Mayumi Muto. A scholar is included among the top collaborators of Mayumi Muto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mayumi Muto. Mayumi Muto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uzawa, Akiyuki, Masahiro Mori, Hiroki Masuda, et al.. (2024). Long-term disability progression in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a retrospective analysis of 101 patients. Journal of Neurology Neurosurgery & Psychiatry. 95(7). 626–629. 4 indexed citations
2.
Uzawa, Akiyuki, Masahiro Mori, Hiroki Masuda, et al.. (2024). Contributions of CSF interleukin-6 elevation to the pathogenesis of myelin oligodendrocyte glycoprotein antibody–associated disease. Multiple Sclerosis Journal. 30(8). 977–982. 4 indexed citations
3.
Masuda, Hiroki, Masahiro Mori, Akiyuki Uzawa, et al.. (2023). Elevated serum levels of bone morphogenetic protein-9 are associated with better outcome in AQP4-IgG seropositive NMOSD. Scientific Reports. 13(1). 3538–3538.
4.
Masuda, Hiroki, Masahiro Mori, Shigeki Hirano, et al.. (2021). Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder. Journal of Neurology Neurosurgery & Psychiatry. 93(1). 32–40. 25 indexed citations
5.
Masuda, Hiroki, Masahiro Mori, Akiyuki Uzawa, et al.. (2021). Clinical difference after the first optic neuritis between aquaporin-4-IgG-associated and myelin oligodendrocyte glycoprotein-IgG-associated disorders. Journal of Neurology. 269(4). 1996–2003. 2 indexed citations
6.
Muto, Mayumi, Masahiro Mori, Akiyuki Uzawa, et al.. (2017). Serum soluble Talin-1 levels are elevated in patients with multiple sclerosis, reflecting its disease activity. Journal of Neuroimmunology. 305. 131–134. 4 indexed citations
7.
Masuda, Hiroki, Masahiro Mori, Akiyuki Uzawa, et al.. (2016). Recovery from optic neuritis attack in neuromyelitis optica spectrum disorder and multiple sclerosis. Journal of the Neurological Sciences. 367. 375–379. 15 indexed citations
8.
Uchida, Tomohiko, Masahiro Mori, Akiyuki Uzawa, et al.. (2016). Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood–brain barrier disruption. Multiple Sclerosis Journal. 23(8). 1072–1084. 47 indexed citations
9.
Muto, Mayumi, Masahiro Mori, Takaki Hiwasa, et al.. (2015). Novel serum autoantibodies against talin1 in multiple sclerosis: Possible pathogenetic roles of the antibodies. Journal of Neuroimmunology. 284. 30–36. 16 indexed citations
10.
Sugiyama, Atsuhiko, Masahiro Mori, Hiroki Masuda, et al.. (2015). Trigeminal root entry zone involvement in neuromyelitis optica and multiple sclerosis. Journal of the Neurological Sciences. 355(1-2). 147–149. 14 indexed citations
11.
Masuda, Hiroki, Masahiro Mori, Akiyuki Uzawa, et al.. (2015). Validation of the Japanese version of the Modified Fatigue Impact Scale and assessment of the effect of pain on scale responses in patients with multiple sclerosis. Clinical and Experimental Neuroimmunology. 6(4). 409–412. 6 indexed citations
12.
Masuda, Saeko, Masahiro Mori, Kimihito Arai, et al.. (2014). Epstein-Barr virus persistence and reactivation in neuromyelitis optica. Journal of Neurology Neurosurgery & Psychiatry. 86(10). 1137–1142. 32 indexed citations
13.
Muto, Mayumi, Masahiro Mori, Yasunori Sato, et al.. (2014). Current symptomatology in multiple sclerosis and neuromyelitis optica. European Journal of Neurology. 22(2). 299–304. 21 indexed citations
14.
Uzawa, Akiyuki, Masahiro Mori, Mayumi Muto, et al.. (2014). Benign neuromyelitis optica is rare in Japanese patients. Multiple Sclerosis Journal. 21(9). 1204–1208. 4 indexed citations
15.
Uzawa, Akiyuki, Masahiro Mori, Setsu Sawai, et al.. (2013). Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks. Clinica Chimica Acta. 421. 181–183. 77 indexed citations
16.
Uzawa, Akiyuki, Masahiro Mori, Mayumi Muto, Saeko Masuda, & Satoshi Kuwabara. (2012). When is neuromyelitis optica diagnosed after disease onset?. Journal of Neurology. 259(8). 1600–1605. 12 indexed citations
17.
Uzawa, Akiyuki, et al.. (2012). CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica. Journal of Neurology Neurosurgery & Psychiatry. 84(5). 517–522. 45 indexed citations
18.
Uzawa, Akiyuki, et al.. (2012). Anti-high mobility group box 1 monoclonal antibody ameliorates experimental autoimmune encephalomyelitis. Clinical & Experimental Immunology. 172(1). 37–43. 41 indexed citations
19.
Furumoto, Hideyuki, et al.. (1998). Disseminated subcutaneous Nocardia farcinica abscesses in a nephrotic syndrome patient. Journal of the American Academy of Dermatology. 38(5). 874–876. 13 indexed citations
20.
Muto, Mayumi, et al.. (1997). Congenitally Acquired Herpes Zoster Infection in a Newborn. Dermatology. 194(3). 276–277. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Markus Breu Breakdown of academic impact, for papers by Csilla Rózsa Breakdown of academic impact, for papers by Yanyu Chang Breakdown of academic impact, for papers by Hiroyuki Yahikozawa Breakdown of academic impact, for papers by Leoni Rolfes Breakdown of academic impact, for papers by Takeshi Kezuka Breakdown of academic impact, for papers by Yuji Tomizawa Breakdown of academic impact, for papers by Ryohei Ohtani Breakdown of academic impact, for papers by Vincent Damotte Breakdown of academic impact, for papers by Yaqing Shu
Rankless by CCL
2026